Iron Sucrose Infusion Guidelines

Indications and Pre-Infusion Assessment

The American Gastroenterological Association recommends documenting the indication for IV iron therapy, including intolerance to oral iron, inadequate response to oral iron, or need for rapid iron repletion, in patients with iron deficiency 1, 2

The American Journal of Hematology guidelines suggest assessing and documenting high-risk features for infusion reactions, including history of severe asthma, eczema, mastocytosis, multiple drug allergies, or prior reaction to IV iron, in patients receiving iron sucrose infusion 3
The Kidney International guidelines recommend documenting the prescribed dose, with a maximum single dose of 200 mg for iron sucrose, and recording the infusion method, which can be given as a 2-5 minute IV push or diluted in 100-150 mL normal saline over 10-30 minutes 1, 2, 4
The American Journal of Hematology guidelines suggest documenting baseline vital signs, including blood pressure, pulse, respiratory rate, oxygen saturation, and temperature, and monitoring vital signs during the first 10 minutes of infusion and throughout the infusion process 3

The American Journal of Hematology guidelines recommend documenting any symptoms during infusion, including pruritus, flushing, urticaria, chest tightness, back pain, joint pain, shortness of breath, or hypotension, and classifying reaction severity if present 3
The American Journal of Hematology guidelines suggest documenting interventions if a reaction occurs, including stopping infusion, switching to normal saline, administering antihistamines, corticosteroids, or epinephrine, and recording response to interventions and time to symptom resolution 3

The American Journal of Hematology guidelines recommend documenting counseling on delayed reactions, including flu-like symptoms, arthralgias, myalgias, fevers that may occur hours to days after infusion, and recording instructions for managing delayed symptoms, including use of NSAIDs for symptomatic relief 3
The Kidney International guidelines suggest documenting the plan for repeat dosing if needed, with iron sucrose given up to 500 mg weekly, and recording the timing of follow-up laboratory monitoring, typically hemoglobin and iron studies rechecked 2-4 weeks after completing iron therapy 4

The American Gastroenterological Association recommends documenting the availability of resuscitation equipment and staff preparedness, including training in recognition and management of infusion reactions, to prevent and manage anaphylaxis 1, 2, 3
The Clinical Nutrition guidelines suggest documenting the cumulative iron dose and monitoring plan to prevent iron overload, including regular ferritin and TSAT monitoring in patients on long-term therapy 6